9960 Share Price Performance
HK$1.28
0.14 (12.28%)
Price HK$1.28
Share PriceHK$1.28
Kindstar Globalgene Technology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
9960 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Kindstar Globalgene Technology, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.10
- 45.40%
- -11.26%
- 15.3%
About 9960
- Founded
- 2003
- Employees
- 3162
- CEO
- WebsiteView website
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. The company was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.
